Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Bortezomib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 23 Neoplasms, Plasma Cell 3 Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 beta-Thalassemia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thalassemia 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoglobulin Light-chain Amyloidosis 1 HIV Infections 1 Disease Progression 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 18 fludarabine 14 pembrolizumab 9 Etoposide 7 Dexamethasone 7 Rituximab 6 Gemcitabine 6 obinutuzumab 5 glofitamab 5 fludarabine phosphate 5 carfilzomib 4 Vincristine 4 Prednisone 4 Nivolumab 4 Carboplatin 4 zanubrutinib 3 ruxolitinib 3 pomalidomide 3 Paclitaxel 3 Lenalidomide 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Doxorubicin 3 venetoclax 2 tocilizumab 2 tisagenlecleucel 2 polatuzumab vedotin 2 ibrutinib 2 enzalutamide 2 duvelisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05572515 2026-04-13

MajesTEC-9

Janssen Research & Development, LLC

Phase 3 Active not recruiting

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡